1008 - Regulatory Affairs, Quality Systems, Policy, and Ethics: AUTOLOGOUS CAR T CELL PRODUCT FROM COVID-19-POSITIVE PATIENT: MANUFACTURING AND REGULATORY CONSIDERATIONS

Autor: Sikder, D., Senechal, B., Wang, X., Geyer, M., Riviere, I.
Zdroj: In Cytotherapy May 2022 24(5) Supplement:S191-S191
Databáze: ScienceDirect